期刊文献+

胃癌术后复发62例的治疗体会

Treatment experience of Postoperative recurrence 62 cases with Gastric cancer
下载PDF
导出
摘要 目的探讨胃癌术后复发的治疗体会,总结胃癌复发的诊治规律。方法选择胃癌复发病例62例,行手术切除或化疗。结果34例可手术切除患者1、3、5年生存率分别为70.3%、31.2%和16.5%。治愈性切除者1、3、5年生存率分别为81.4%、42.3%和13.6%;姑息性切除者1、3、5年生存率分别为71.5%、22.8%和8.1%。28例化疗后完全缓解(CR)4例,部分缓解(PR)11例,稳定(SD)10例,进展(PD)3例,有效率为53.6%。结论胃癌根治术后复发应该积极手术和化疗治疗。 Objective To explore the experience in treatment of postoperative recurrence in patients with gastric cancer and to summarize the rules for its diagnosis and treatment. Methods The clinical data of 62 cases of postoperative recurrence with gastric cancer treated by surgical resection or chemotherapy. Results 34 cases of surgical resection patients'1,3 ,5 - year survival rates were 70.3%, 31.2% and 16.5%. Cura- tive resection patients ~ 1,3,5 - year survival rates were 81.4 %, 42.3 % and 13.6 %. Palliative resection patients" 1,3,5 - year survival rates were 71.5%, 22.8% and 8.1%. In 28 cases after chemotherapy,there were CR 4 cases, PR 11 cases, SD 10 cases, PD 3 cases. The response rate was 53.6%. Conclusion Re - treatment of gastric cancer surgery and chemotherapy is an effective method of postoperative recurrence with gastric cancer.
作者 温子仪
出处 《临床和实验医学杂志》 2010年第7期503-504,共2页 Journal of Clinical and Experimental Medicine
关键词 胃癌复发 再手术 化疗 Recurrence of gastric cancel Re - operation Chemotherapy
  • 相关文献

参考文献7

二级参考文献38

  • 1戚晓东,邢承忠,王舒宝,齐春莲,张文范,陈峻青,王梅先.Borrmann 4型胃癌的临床病理特点及外科治疗效果的评价[J].实用肿瘤学杂志,1994,8(1):63-65. 被引量:6
  • 2陈峻青.胃癌根治术后复发形式和治疗方法的选择[J].中国实用外科杂志,1995,15(12):709-710. 被引量:55
  • 3刘庆华,陈峻青.胃癌腹腔内游离癌细胞与预后(附100例临床报告)[J].中国实用外科杂志,1996,16(10):616-617. 被引量:29
  • 4Tanabe K,Yoshida K,Hamai Y,et al.Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases [J].Gan To Kagaku Ryoho,2005;32(8):1145
  • 5Sakaguchi Y,Kabashima A,Okita K,et al.Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer [J].Gastric Cancer,2005;8(2):111
  • 6Johira H,Yunoki S,Kawata N,et al.Results of treatment of far advanced and recurrent stomach cancer with TS-1 [J].Gan To Kagaku Ryoho,2005;32(2):195
  • 7Yonemori K,Shimada Y,Goto A,et al.Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1,an oral fluoropyrimidine derivative,as single-agent chemotherapy [J].Gastric Cancer,2004;7(4):204
  • 8Shin SJ,Chun SH,Kim KO,et al.The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer:a multicenter phase Ⅱ study [J].Korean J Intern Med,2005;20(2):135
  • 9Yeh KH,Lu YS,Hsu CH,et al.Phase Ⅱ study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer [J].Oncology,2005;69(1):88
  • 10Cho EK,Lee WK,Im SA,et al.A phase Ⅱ study of epirubicin,cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer [J].Oncology,2005;68(4-6):333

共引文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部